Creating Biomedical Technologies to Improve Health


April 16, 2015

Stealth Mutagen Drives HIV to Suicide

NIBIB-funded researchers have partnered with a collaborative group to develop a new generation of anti-viral treatments. The group reports the development of a compound that drives HIV to lethal mutagenesis. The strategy takes advantage of HIV's already high mutation rate by forcing it above an intolerable threshold where the virus acquires so many mutations that it breaks down and can no longer replicate. Read more at UChicago News.